Position in EW
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,853,701
+$392,206 QoQ
Shares Held
75,765
-6.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#300
of 1,323 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $168,273,932 across 34 Medical Devices names. EW ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
210,670 | $66,327,342 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
579,138 | $37,070,623 | |
| 3 | MDT |
Medtronic plc
|
359,859 | $28,151,769 | |
| 4 | ABT |
Abbott Laboratories
|
218,899 | $19,862,895 | |
| 5 | BSX |
Boston Scientific Corp
|
176,096 | $7,515,777 | |
| 6 | EW |
Edwards Lifesciences Corp
This page
|
75,765 | $6,853,701 | |
| 7 | PROF |
Profound Medical Corp.
|
138,110 | $918,431 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,109 | $525,923 |
All Filings in EW
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,853,701 | 75,765 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $6,461,495 | 80,688 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $532,045 | 6,241 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $520,514 | 6,693 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $481,304 | 6,154 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $432,125 | 5,962 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $375,258 | 5,069 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $519,341 | 7,870 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $573,617 | 6,210 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $602,314 | 6,303 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||